Oncolytics Biotech, Inc (NASDAQ: ONCY) is -34.27% lower on its value in year-to-date trading and has touched a low of $0.73 and a high of $1.53 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ONCY stock was last observed hovering at around $0.74 in the last trading session, with the day’s gains setting it 0.15%.
Currently trading at $0.89, the stock is 1.02% and -15.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.2 million and changing 19.60% at the moment leaves the stock -14.68% off its SMA200. ONCY registered -32.26% loss for a year compared to 6-month gain of -12.14%. The firm has a 50-day simple moving average (SMA 50) of $1.0468 and a 200-day simple moving average (SMA200) of $1.04025.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -16.28% loss in the last 1 month and extending the period to 3 months gives it a -3.95%, and is 6.19% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.88% over the week and 6.67% over the month.
Oncolytics Biotech, Inc (ONCY) has around 27 employees, a market worth around $68.39M and $0.00M in sales. Distance from 52-week low is 21.63% and -42.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-278.00%).
The EPS is expected to shrink by -0.20% this year
47.0 institutions hold shares in Oncolytics Biotech, Inc (ONCY), with institutional investors hold 1.83% of the company’s shares. The shares outstanding are 77.07M, and float is at 75.99M with Short Float at 3.49%. Institutions hold 1.76% of the Float.
The top institutional shareholder in the company is INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC with over 0.2 million shares valued at $0.2 million. The investor’s holdings represent 0.2637 of the ONCY Shares outstanding. As of 2024-06-30, the second largest holder is SEEDS INVESTOR LLC with 0.19 million shares valued at $0.19 million to account for 0.2524 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 0.14 million shares representing 0.1841 and valued at over $0.14 million, while CITADEL ADVISORS LLC holds 0.1822 of the shares totaling 0.14 million with a market value of $0.14 million.
